Tiziana Life Sciences Ltd (NASDAQ:TLSA) Sees Significant Decrease in Short Interest

Tiziana Life Sciences Ltd (NASDAQ:TLSA) was the target of a significant decrease in short interest in August. As of August 31st, there was short interest totalling 127,100 shares, a decrease of 53.7% from the August 15th total of 274,700 shares. Based on an average trading volume of 265,800 shares, the days-to-cover ratio is currently 0.5 days.

Tiziana Life Sciences Price Performance

Shares of Tiziana Life Sciences stock traded down $0.00 during mid-day trading on Friday, hitting $0.92. 39,551 shares of the stock were exchanged, compared to its average volume of 194,620. Tiziana Life Sciences has a twelve month low of $0.41 and a twelve month high of $1.74. The company has a 50-day simple moving average of $1.03 and a 200 day simple moving average of $0.79.

About Tiziana Life Sciences

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.